Blog

Elsight (ASX: ELS) receives first large order in Telemedicine vertical

Posted by Justin Rosenberg on 10-Dec-2018 10:14:29
Find me on:
LinkedIn

We're pleased to share today's ASX announcement that ELS received its first large order from its French-based partner, Alrena, in the new Telemedicine vertical.

Alrena was able to place the order after securing its first large-scale investment (2 million Euros) that was reviewed and approved by Project Evaluation Committee of Chamber of Commerce (CCI Val-De-Marne). The investment will be jointly funded by BPIFrance (The Bank of Entrepreneurs of France) as well as by private and other institutional investors. This investment allows Alrena to scale up its sales and operations.

This is the first large order from Alrena since they entered into the exclusive telemedicine deal with Elsight conditional on orders totalling 6 million Euros over 3 years.

Please click here for today's ASX announcement.

Please contact us for further queries or subscribe (on the right of this page) to receive further updates.
 
Medicase
 

Justin Rosenberg

Corporate Finance - Executive Director

Gleneagle Securities (Aust) Pty Limited

Level 27, 25 Bligh Street, Sydney NSW 2000

Ph: +612 8277 6683

Email: justin.rosenberg@gleneagle.com.au

Topics: Technology, Israel, microcap, Announcement

About this blog

Gleneagle Securities provides timely and accurate market research and data.

Subscribe to Email Updates

Recent Posts

Posts by Topic

see all

Contact:

Office Address: Level 27, 25 Bligh Street, Sydney NSW 2000, Australia
Phone: +61 2 8277 6655

Gleneagle Securities (Aust) Pty Ltd
ABN 58 136 930 526 AFSL 337 985

Gleneagle Asset Management Limited
ABN 29 103 162 278 AFSL 226 199

Disclaimer:

The information on this website is not intended to be an inducement, offer or solicitation to anyone outside of Australia. Gleneagle Securities (Aust) Pty Ltd, ABN 58 136 930 526, (Gleneagle) holds an Australian Financial Services Licence (AFSL) to carry on financial services business in Australia, limited to the financial services covered by its AFSL No. 337985.

Any Information or advice contained on this website is general in nature and has been prepared without taking into account your objectives, financial situation or needs. Before acting on any information or advice on this website, you should consider its appropriateness (and any relevant product) having regard to your circumstances and we strongly recommend that you seek independent financial advice.

All financial products involve risk and you should ensure that you understand the risks involved as not all financial products are suitable for everyone. Trading in certain products carries a higher level of risk as you may incur a loss in excess of the amount you originally invested. Past performance of any product described on this website is not a reliable indication of future performance.